$ATRA Atara Biotherapeutics, Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Atara Biotherapeutics, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Atara Biotherapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Atara Biotherapeutics, Inc. for free.

CIK Number: 0001604464
IRS Number: 460920988
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: ATRA
Company Address: 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO 94080

Atara Biotherapeutics, Inc. operates as a clinical stage biopharmaceutical company which focuses on developing novel therapeutics for serious unmet medical needs, with an initial focus on muscle wasting conditions and oncology. Its product candidates are biologics targeting myostatin and activin, members of the transforming growth factor-beta, protein superfamily, which play roles in the growth and maintenance of muscle and many other body tissues. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA.

Market Capitalization: $434.34M
Prev close: $15.05
Average Daily Volume: 231,402
Days Low: $14.70
Year Low: $12.45
Year High: $25.73

Atara Biotherapeutics, Inc. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Ciechanover Isaac E.Chief Executive Officer435,1786,549,429shares bought: 520,446 / shares sold: -601,057 SELLSep 21 20175 days ago
Clark Mitchall G.EVP & Chief R & QA Officer162,1512,440,373shares bought: 92,769 / shares sold: -17,101 STRONG BUYAug 17 20171 month ago
Fust Matthew KDirector28,901434,960shares bought: 15,013 / shares sold: 0 STRONG BUYAug 17 20171 month ago
Gallagher Carol GiltnerDirector108,9221,639,276shares bought: 21,195 / shares sold: -6,919 STRONG BUYAug 17 20171 month ago
Haqq ChristopherEVP, R&D & Chief Scientific Of349,3055,257,040shares bought: 144,475 / shares sold: -90,410 BUYSep 18 20178 days ago
MCGRATH JOHNEVP & Chief Financial Officer125,1571,883,613shares bought: 107,838 / shares sold: -70,595 BUYAug 17 20171 month ago
Sofer GadEVP & Chief Strategy Officer257,4093,874,005shares bought: 194,190 / shares sold: -61,492 STRONG BUYAug 17 20171 month ago

View all Atara Biotherapeutics, Inc. insiders.

Atara Biotherapeutics, Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Sep 21 2017ATRAAtara Biotherapeut ...Ciechanover Isaac E.Chief Executive Off ...SellS15.562,20034,232432,978435.2 K to 433 K (-0.51 %)
Sep 21 2017ATRAAtara Biotherapeut ...Ciechanover Isaac E.Chief Executive Off ...SellS15.512,20034,122435,178437.4 K to 435.2 K (-0.50 %)
Sep 18 2017ATRAAtara Biotherapeut ...Haqq ChristopherEVP, R&D & Chief Sc ...SellS15.306,00091,800349,305355.3 K to 349.3 K (-1.69 %)
Sep 08 2017ATRAAtara Biotherapeut ...Ciechanover Isaac E.Chief Executive Off ...SellS14.982,20032,956437,378439.6 K to 437.4 K (-0.50 %)
Sep 08 2017ATRAAtara Biotherapeut ...Ciechanover Isaac E.Chief Executive Off ...SellS15.052,20033,110439,578441.8 K to 439.6 K (-0.50 %)
Aug 24 2017ATRAAtara Biotherapeut ...Ciechanover Isaac E.Chief Executive Off ...SellS13.512,20029,722441,778444 K to 441.8 K (-0.50 %)
Aug 24 2017ATRAAtara Biotherapeut ...Ciechanover Isaac E.Chief Executive Off ...SellS13.562,20029,832443,978446.2 K to 444 K (-0.49 %)
Aug 17 2017ATRAAtara Biotherapeut ...Fust Matthew KDirectorOption ExerciseM0.001,60303,739
Aug 17 2017ATRAAtara Biotherapeut ...Fust Matthew KDirectorBuyM0.001,603028,90127.3 K to 28.9 K (+5.87 %)
Aug 17 2017ATRAAtara Biotherapeut ...Gallagher Carol GiltnerDirectorOption ExerciseM0.0081802,179
Aug 17 2017ATRAAtara Biotherapeut ...Gallagher Carol GiltnerDirectorOption ExerciseM0.001,54803,097
Aug 17 2017ATRAAtara Biotherapeut ...Gallagher Carol GiltnerDirectorSellS14.301,18416,931108,556109.7 K to 108.6 K (-1.08 %)
Aug 17 2017ATRAAtara Biotherapeut ...Gallagher Carol GiltnerDirectorBuyM0.008180109,740108.9 K to 109.7 K (+0.75 %)
Aug 17 2017ATRAAtara Biotherapeut ...Gallagher Carol GiltnerDirectorBuyM0.001,5480108,922107.4 K to 108.9 K (+1.44 %)
Aug 17 2017ATRAAtara Biotherapeut ...Soffer GadEVP & Chief Strateg ...Option ExerciseM0.004,14506,910

View all Atara Biotherapeutics, Inc. insider transactions.